Joint (NASDAQ:JYNT) Rating Increased to Buy at StockNews.com

Joint (NASDAQ:JYNT) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Monday.

JYNT has been the subject of a number of other reports. B. Riley lifted their price target on shares of Joint from $12.00 to $20.00 and gave the company a “buy” rating in a research report on Monday. Roth Mkm restated a “buy” rating and set a $16.00 price target (up from $13.00) on shares of Joint in a research report on Friday, May 3rd. Finally, TheStreet downgraded Joint from a “c-” rating to a “d” rating in a report on Thursday, March 7th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $22.00.

Joint Price Performance

NASDAQ JYNT opened at $16.13 on Monday. Joint has a 1-year low of $7.31 and a 1-year high of $16.39. The company has a market cap of $240.98 million, a PE ratio of -21.51 and a beta of 1.58. The stock’s 50 day simple moving average is $12.30 and its 200-day simple moving average is $10.27.

Joint (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.03 by $0.04. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%. The firm had revenue of $30.61 million during the quarter, compared to analysts’ expectations of $29.63 million. On average, equities research analysts anticipate that Joint will post 0.13 EPS for the current fiscal year.

Institutional Trading of Joint

Several institutional investors and hedge funds have recently made changes to their positions in JYNT. Skylands Capital LLC raised its stake in shares of Joint by 20.3% during the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock worth $5,801,000 after purchasing an additional 101,850 shares during the last quarter. First Foundation Advisors purchased a new stake in shares of Joint in the third quarter valued at approximately $1,336,000. JCP Investment Management LLC grew its stake in shares of Joint by 15.3% during the 1st quarter. JCP Investment Management LLC now owns 112,800 shares of the company’s stock worth $1,473,000 after purchasing an additional 15,000 shares during the period. Verus Capital Partners LLC lifted its stake in shares of Joint by 24.0% in the third quarter. Verus Capital Partners LLC now owns 108,370 shares of the company’s stock valued at $974,000 after purchasing an additional 20,950 shares during the period. Finally, O Brien Greene & Co. Inc boosted its position in Joint by 12.1% during the third quarter. O Brien Greene & Co. Inc now owns 102,020 shares of the company’s stock worth $917,000 after purchasing an additional 11,000 shares in the last quarter. 76.88% of the stock is owned by hedge funds and other institutional investors.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.